Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAART in HIV Elite Controllers
NCT01025427Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2009
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir, tenofovir disoproxil fumarate, emtricitabine in human immunodeficiency virus infection (HIV), sponsored by University of California, San Francisco. Started Dec 2009; status: completed.
02
Drugs
raltegravirtenofovir disoproxil fumarateemtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01025427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025427.